ivermectin oral / Generic mfg. 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«12...8687888990919293949596...129130»
  • ||||||||||  ivermectin oral / Generic mfg.
    Review, Journal:  Paediatrics: how to manage scabies. (Pubmed Central) -  Apr 10, 2021   
    Oral ivermectin, where available, is reserved for use in high-risk cases in children or in mass drug administration programmes in endemic communities...Although time consuming and labour intensive for caregivers, the implementation of appropriate treatment strategies usually results in prompt cure for the child and their contacts. Here, we provide a summary of treatments and recommendations for the management of paediatric scabies.
  • ||||||||||  Journal:  The American Heartworm Society and Association of Shelter Veterinarians' 2019 Shelter Heartworm Management Practices Survey. (Pubmed Central) -  Mar 25, 2021   
    Most respondents provided monthly heartworm preventives for dogs (81.1%) and used oral ivermectin products per product labels (67.2%) to do so...Protocols typically included adjunctive treatment with doxycycline or minocycline (92.3%), prednisone (71.3%), and macrocyclic lactones (58.6%)...Heartworm prevention was provided by 29.9% of respondents that admitted cats and 9.9% of those that admitted ferrets. These results can be used to identify challenges to meeting recommended practices regarding prevention, diagnosis, and treatment of heartworm disease in the animal shelter setting and to target operational and educational resources toward the areas of greatest need.
  • ||||||||||  ivermectin oral / Generic mfg.
    Enrollment change, Trial completion date, Trial primary completion date:  SAINT-PERU: Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19 (clinicaltrials.gov) -  Mar 18, 2021   
    P2a,  N=186, Recruiting, 
    These results can be used to identify challenges to meeting recommended practices regarding prevention, diagnosis, and treatment of heartworm disease in the animal shelter setting and to target operational and educational resources toward the areas of greatest need. N=68 --> 186 | Trial completion date: Jan 2021 --> Apr 2021 | Trial primary completion date: Dec 2020 --> Apr 2021
  • ||||||||||  albendazole / Generic mfg.
    Trial completion, Trial completion date, Trial primary completion date:  Efficacy and Safety of IVM/ALB Co-administration (clinicaltrials.gov) -  Mar 17, 2021   
    P2/3,  N=1673, Completed, 
    N=68 --> 186 | Trial completion date: Jan 2021 --> Apr 2021 | Trial primary completion date: Dec 2020 --> Apr 2021 Active, not recruiting --> Completed | Trial completion date: Dec 2020 --> Jul 2020 | Trial primary completion date: Feb 2020 --> May 2020
  • ||||||||||  ivermectin oral / Generic mfg.
    Trial completion date, Trial primary completion date:  Study in COvid-19 Patients With iveRmectin (CORVETTE-01) (clinicaltrials.gov) -  Mar 7, 2021   
    P2,  N=240, Recruiting, 
    However, future studies should be conducted to assess the interaction between P-gp inhibitors on the pharmacokinetics of tramadol. Trial completion date: Mar 2021 --> Sep 2021 | Trial primary completion date: Mar 2021 --> Sep 2021
  • ||||||||||  ivermectin oral / Generic mfg.
    Enrollment open:  Inhaled Ivermectin and COVID-19 (clinicaltrials.gov) -  Feb 23, 2021   
    P3,  N=80, Recruiting, 
    Trial completion date: Jan 2022 --> Mar 2023 | Initiation date: Nov 2020 --> Mar 2021 | Trial primary completion date: Jan 2022 --> Mar 2023 Not yet recruiting --> Recruiting
  • ||||||||||  metformin / Generic mfg., ivermectin oral / Generic mfg., fluvoxamine / Generic mfg.
    Enrollment change, Trial primary completion date:  COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19) (clinicaltrials.gov) -  Feb 21, 2021   
    P2/3,  N=750, Recruiting, 
    Reinfection on return to community is common while scabies remains endemic. N=70 --> 750 | Trial primary completion date: Sep 2021 --> Jun 2021
  • ||||||||||  ivermectin / Generic mfg.
    ivermectin (Twitter) -  Jan 30, 2021   
  • ||||||||||  ivermectin / Generic mfg., rifampicin / Generic mfg.
    Journal:  Efficient degradation of ivermectin by newly isolated Aeromonas taiwanensis ZJB-18,044. (Pubmed Central) -  Jan 30, 2021   
    Therefore, the IVM tolerance of strain ZJB-18,044 may be due to the regulation of the intracellular IVM concentration by the activated macrolide efflux pump(s). With the high IVM degradation efficiency, A. taiwanensis ZJB-18,044 may serve as a bioremediation agent for IVM and other macrolides in the environment.